Nonadherence to antihypertensive drugs a systematic review and meta-analysis

Medicine (United States)

Volumn 96, Issue 4, 2017, Pages

  Abegaz, Tadesse Melaku ^a   Shehab, Abdulla ^b   Gebreyohannes, Eyob Alemayehu ^a   Bhagavathula, Akshaya Srikanth ^a   Elnour, Asim Ahmed ^c  

^a UNIVERSITY OF GONDAR   (Ethiopia)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c Fathima College of Health Sciences   (United Arab Emirates)

Author keywords

Adherence; Antihypertensive; Cardiovascular diseases; Hypertension; Morisky medication adherence scale; Nonadherence; Uncontrolled blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AFRICAN; ASIAN; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL OUTCOME; HUMAN; HYPERTENSION; MEDICATION COMPLIANCE; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; TREATMENT REFUSAL; ADULT; AGED; FEMALE; MALE; MIDDLE AGED; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SEX FACTORS;

EID: 85013728684     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005641     Document Type: Review

References (58)

1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-60.
2. Burnier M. Drug adherence in hypertension. Pathophysiology and Pharmacotherapy of Cardiovascular Disease 2015; Springer International Publishing, Switzerland: 919-933.
3. Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence for hypertension control. J Hypertens 2008;10:348-54.
4. Svarstad BL, Chewning BA, Sleath BL, et al. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Counsel 1999;37:113-24.
5. Kim MT, Hill MN, Bone LR, et al. Development and testing of the Hill-Bone Compliance to high blood pressure therapy scale. Progress Cardiovasc Nurs 2000;15:90-6.
6. Culig J, Leppee M, Boskovic J, et al. Determining the difference in medication compliance between general patient population and patients receiving antihypertensive therapy: a case study. Arch Pharm Res 2011;34:1143-52.
7. Haidich AB. Meta-analysis in medical research. Hippokratia 2010;14(suppl 1):29-37.
8. Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-9.
9. Mugwano I, Kaddumukasa M, Mubenyi L, et al. Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: a cross-sectional study. BMC Res Notes 2016;9:3.
10. Sadeghi E, Behnood-Rod A, Aerab-Sheibani H, et al. Controlled blood pressure in Iranian patients: a multi-center report. Global J Health Sci 2016;8:188-95.
11. Cummings DM, Wu J, Cene C, et al. Perceived social standing, medication nonadherence, and systolic blood pressure in the rural south. J Rural Health 2016;32:156-63.
12. Hall E, Lee S, Clark PC, et al. Social ecologyof adherence tohypertension treatment in Latino migrant and seasonal farmworkers. J Trascult Nurs 2016;27:33-41.
13. Mohammad Y, Amal A, Sanaa A, et al. Evaluation of medication adherence in Lebanese hypertensive patients. J Epidemiol Global Health 2016;6:157-67.
14. Yue Z, Li C, Weilin Q, et al. Application of the health belief model to improve the understanding of antihypertensive medication adherence among Chinese patients. Patient Educ Counsel 2015;98:669-73.
15. Pandey A, Raza F, Velasco A, et al. Comparison of Morisky medication adherence scale with therapeutic drug monitoring in apparent treatmentresistant hypertension. J Am Soc Hypertens 2015;9:420-6.
16. Akintunde AA, Akintunde TS. Antihypertensive medications adherence among Nigerian hypertensive subjects in a specialist clinic compared to a general outpatient clinic. Ann Med Health Sci Res 2015;5:173-8.
17. Hou Y, Zhang D, Gu J, et al. The association between self-perceptions of aging and antihypertensive medication adherence in older Chinese adults. Aging Clin Exp Res 2015;28:1113-20.
18. Saadat Z, Nikdoust F, Aerab-Sheibani H, et al. Adherence to antihypertensives in patients with comorbid conditions. Nephr Urol Mon 2015;7:e299863.
19. Kubo MN, Kayima JK, Were AJ, et al. Factors associated with uncontrolled hypertension among renal transplant recipients attending nephrology clinics in Nairobi, Kenya. J Transplant 2015;2015:746563.
20. Kim J, Lee W, Hong Y, et al. Psychometric properties of a short self-reported measure of medication adherence among patients with hypertension treated in a busy clinic setting in Korea. J Epidemiol 2014;24:132-40.
21. Li WTL, Kang CD, Tsang PPM, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: a cross-sectional study. Int J Cardiol 2015;182:250-7.
22. Okwuonu CG, Ojimadu NE, Okaka EI, et al. Patient-reported barriers to hypertension control in a Nigerian population. Int J Gen Med 2014;7:345-53.
23. Fernandez-Arias M, Acuna-Villaorduna A, Miranda JJ, et al. Adherence to pharmacotherapy and medication-related beliefs in patients with hypertension in Lima, Peru. PLoS ONE 2014;9:e112875.
24. Girma F, Emishaw S, Alemseged F, et al. Compliance with antihypertensive treatment and associated factors among hypertensive patients on follow-up in Jimma University specialized hospital, Jimma, south west Ethiopia: a quantitative cross-sectional study. J Hypertens 2014;3:174.
25. Lee GKY, Wang HHX, Liu KQL, et al. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky medication adherence scale. PLoS ONE 2013;8:e62775.
26. Cuffee YL, Hargraves JL, Briesacher BA, et al. Reported racial discrimination, trust in physicians, and medication adherence among inner-city African Americans with hypertension. Am J Public Health 2013;103:e55-62.
27. Kretchy I, Owusu-Daaku F, Danquah S. Spiritual and religious beliefs: do they matter in the medication adherence behavior of hypertensive patients? BioPsychoSocial Med 2013;7:15.
28. Ramli A, Ahmad NS, Paridathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer Adherence 2012;6:613-22.
29. Migneault JP, Dedier JJ, Wright JA, et al. A culturally adapted telecommunication system to improve physical activity, diet quality, and medication adherence among hypertensive African-Americans: a randomized controlled trial. Ann Behav Med 2012;43:62-73.
30. Muntner P, Levitan EB, Joyce C, et al. Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure. J Clin Hypertens 2013;15:112-7.
31. Zyoud SH, Al-Jabi S, Swelleh WM, et al. Relationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Quality Life Outcome 2013;11:191.
32. Leung LB, Busch AM, Nottage SL, et al. Approach to antihypertensive adherence: a feasibility study on the use of students health coaches for uninsured hypertensive adults. Behav Med 2012;38:19-27.
33. Breaux-Shropshire TL, Brown KC, Pryor ER, et al. Relationship of blood pressure self-monitoring, medication adherence, self-efficacy, stage of change, and blood pressure control among municipal workers with hypertension. Workplace Health Saf 2012;60:303-11.
34. Oliveira-Filho AD, Barreto-Filho JA, Neves SJ, et al. Association between the 8-item Morisky medication adherence scale (MMAS-8) and blood pressure control. Arq Bras Cardiol 2012;99:649-58.
35. Holt EW, Muntner P, Joyce CJ, et al. Health-related quality of life and antihypertensive medication adherence among older adults. Age Ageing 2010;39:481-7.
36. Berni A, Ciani E, Cecioni I, et al. Adherence to antihypertensive therapy affects ambulatory atrial stiffness index. Eur J Int Med 2011;22:93-8.
37. Buckley L, Labonville S, Barr J. A systematic review of beliefs about hypertension and its treatment among African Americans. Curr Hypertens Rep 2016;18:52.
38. Hyman DJ, Pavlik V. Medication adherence and resistant hypertension. J Hum Hypertens 2015;29:213-8.
39. Waeber W, Feihi F. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy. EuroIntervention 2013;9(suppl):R29-34.
40. Carrea NB, Paula de Faria A, Ritter AVM, et al. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension. J Am Soc Hypertens 2016;10:510-6.e1.
41. Lewis LM. Factors associated with medication adherence in hypertensive blacks: a review of the literature. J Cardiovasc Nurs 2012;27:208-19.
42. De Geest S, Ruppar T, Berben L, et al. Medication non-adherence as a critical factor in the management of presumed resistant hypertension: a narrative review. EuroIntervention 2014;9:1102-9.
43. Pladevall M, Brotons C, Gabriel R, et al. Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation 2010;122:1183-91.
44. Conn VS, Enriquez M, Ruppar TM, et al. Meta-analysis of theory use in medication adherence intervention research. Am J Health Behav 2016;40:155-71.
45. Ghembaza MA, Senoussaoui Y, Tani MK, et al. Impact of patient knowledge of hypertension complications on adherence to antihypertensive therapy. Curr Hypertens Rev 2014;10:41-8.
46. Conn VS, Rupper TM, Chase JD, et al. Interventions to improve medication adherence in hypertensive patients: systematic review and meta-analysis. Curr Hypertens Rep 2015;17:94.
47. Holmes HM, Luo R, Hanlon JT, et al. Ethnic disparities in adherence to antihypertensive medications of Medicare part D beneficiaries. J Am Geriatr Soc 2012;60:1298-303.
48. Wong MC, Jiang JY, Griffiths SM. Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study. J Clin Pharmacol 2010;50:598-605.
49. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular diseases and death: a systematic review and meta-analysis. Lancet 2016;387:957-67.
50. James P, Oparil S, Carter B, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20.
51. Egan BM. Treatment resistant hypertension. Ethn Dis 2015;25:495-8.
52. de Oliveira-Filho AD, Costa FA, Neves SJ, et al. Pseudoresistant hypertension due to poor medication adherence. Int J Cardiol 2014;172:e309-10.
53. Holt E, Joyce C, Dornelles A, et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 2013;61:558-64.
54. Coons SJ, Sheahan SL, Martin SS, et al. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994;16:110-7.
55. Konin C, Adoh M, Coulibaly I, et al. Black Africans' compliance to antihypertensive treatment. J Hypertens 2007;25:A11.
56. Pio M, Baragou S, Afassinou Y, et al. Adherence to hypertension and its determinants in the cardiology department of the university hospital of Lome Tokoin. Pan African Med J 2012;14:48.
57. Ikama MS, Nsitou BM, Loumouamou M, et al. Drug compliance and its factors in a group of hypertensive Congolese. Pan African Med J 2013;15:121.
58. Ghozzi H, Kassis M, Hakim A, et al. Medication adherence of a sample of hypertensive patients in the region of Sfax (Tunisia). Ann Cardiol Angeiol 2010;59:131-7.